✦ LIBER ✦

Imatinib resistance in gastrointestinal stromal tumors

✍ Scribed by Lei L. Chen; Mahyar Sabripour; Robert H. I. Andtbacka; Shreyaskumar R. Patel; Barry W. Feig; Homer A. Macapinlac; Haesun Choi; Elsie F. Wu; Marsha L. Frazier; Robert S. Benjamin

Book ID: 107546391
Publisher: Current Science Inc.
Year: 2005
Tongue: English
Weight: 812 KB
Volume: 7
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-005-0053-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel tyrosine kinase switch is a mech

A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors

✍ Mahadevan, D; Cooke, L; Riley, C; Swart, R; Simons, B; Della Croce, K; Wisner, L 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 310 KB

Mechanisms of resistance to imatinib and

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor

✍ Wei-Lien Wang; Anthony Conley; David Reynoso; Laura Nolden; Alexander J. Lazar; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 384 KB

Molecular mechanisms of secondary imatin

Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors

✍ Chun-Meng Wang; Kai Huang; Ye Zhou; Chun-Yan Du; Yan-Wei Ye; Hong Fu; Xiao-Yan Z 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 312 KB

Molecular analysis of secondary kinase m

Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors

✍ Ken-Hong Lim; Ming-Jer Huang; Li-Tzong Chen; Tsang-En Wang; Chien-Liang Liu; Che 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 194 KB

Novel V600E BRAF mutations in imatinib-n

Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors

✍ Narasimhan P. Agaram; Grace C. Wong; Tianhua Guo; Robert G. Maki; Samuel Singer; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

## Abstract __BRAF__ and __NRAS__ are commonly mutated in cancer and represent the most frequent genetic events in malignant melanoma. More recently, a subset of melanomas was shown to overexpress KIT and harbor __KIT__ mutations. Although most gastrointestinal stromal tumors (GISTs) exhibit activa

KRAS and BRAF Mutations Predict Primary

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

✍ Miranda, C.; Nucifora, M.; Molinari, F.; Conca, E.; Anania, M. C.; Bordoni, A.; 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 883 KB